908 Devices Inc. $MASS Shares Bought by First Eagle Investment Management LLC

Key Points

• First Eagle Investment Management more than doubled its position in 908 Devices, raising its stake 125.9% to 603,962 shares (about a 1.68% ownership) worth roughly $5.29 million at quarter end.
• Q4 results beat expectations—GAAP EPS of ($0.05) vs. ($0.06) expected and revenue of $17.38M vs. $16.19M—and management issued FY‑2026 revenue guidance of $64.5M–$67.5M, a catalyst behind a roughly 6.6% share price gain.
• Despite the beat, the company remains unprofitable on a GAAP basis with negative margins and ROE; analyst sentiment is mixed (consensus "Hold", $12 target) and the CFO recently sold 23,175 shares, reducing insider ownership.

First Eagle Investment Management LLC lifted its stake in shares of 908 Devices Inc. (NASDAQ:MASS - Free Report) by 125.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 603,962 shares of the company's stock after acquiring an additional 336,584 shares during the quarter. First Eagle Investment Management LLC owned about 1.68% of 908 Devices worth $5,291,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. AQR Capital Management LLC bought a new position in 908 Devices during the 1st quarter valued at $365,000. Nisa Investment Advisors LLC lifted its holdings in shares of 908 Devices by 453.2% in the second quarter. Nisa Investment Advisors LLC now owns 3,784 shares of the company's stock valued at $27,000 after buying an additional 3,100 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in 908 Devices during the second quarter valued at about $1,515,000. Campbell & CO Investment Adviser LLC acquired a new position in 908 Devices during the second quarter worth about $775,000. Finally, Geode Capital Management LLC raised its position in 908 Devices by 11.7% in the second quarter. Geode Capital Management LLC now owns 658,603 shares of the company's stock worth $4,697,000 after acquiring an additional 68,764 shares in the last quarter. Institutional investors own 88.06% of the company's stock.

Key Stories Impacting 908 Devices

Here are the key news stories impacting 908 Devices this week:

• Positive Sentiment: Q4 results beat estimates: GAAP loss per share of ($0.05) beat the consensus ($0.06) and revenue of $17.38M topped the $16.19M estimate — that top‑line surprise is a near‑term catalyst supporting the rally. Press Release
• Positive Sentiment: FY‑2026 revenue outlook provided at $64.5M–$67.5M, which brackets the consensus (~$65.4M) and signals modest top‑line growth expectations for the year — investors often reward clear guidance that meets or slightly exceeds Street forecasts. Company Results & Guidance (Yahoo)
• Neutral Sentiment: Management materials and the earnings call are available (conference call recording and slide deck), giving investors more detail to parse execution and margins — useful but not an immediate directional driver on its own. Slide Deck
• Neutral Sentiment: Detailed earnings transcripts and coverage (Seeking Alpha, Yahoo) are now posted for deeper read-throughs of commentary and questions; these will influence sentiment as investors digest management’s color on product demand and margin trajectory. Earnings Call Transcript (Seeking Alpha)
• Negative Sentiment: Despite the beat, the company remains unprofitable on a GAAP basis with negative net margin (~‑7.2%) and negative return on equity (~‑22.3%), which keeps the stock’s longer‑term valuation and risk elevated until sustained profitability is demonstrated. Zacks Summary

908 Devices Stock Up 6.6%

Shares of NASDAQ MASS opened at $6.74 on Thursday. 908 Devices Inc. has a 12 month low of $2.67 and a 12 month high of $9.34. The company has a market cap of $243.92 million, a price-to-earnings ratio of 12.25 and a beta of 0.47. The business has a fifty day simple moving average of $6.18 and a 200-day simple moving average of $6.64.

908 Devices (NASDAQ:MASS - Get Free Report) last issued its quarterly earnings results on Tuesday, March 3rd. The company reported ($0.05) earnings per share for the quarter, topping analysts' consensus estimates of ($0.06) by $0.01. 908 Devices had a negative return on equity of 14.87% and a net margin of 34.68%.The firm had revenue of $17.38 million for the quarter, compared to analysts' expectations of $16.19 million. As a group, sell-side analysts expect that 908 Devices Inc. will post -1.99 EPS for the current fiscal year.

Insider Buying and Selling at 908 Devices

In other news, CFO Joseph H. Iv Griffith sold 23,175 shares of the business's stock in a transaction that occurred on Monday, February 2nd. The shares were sold at an average price of $6.18, for a total transaction of $143,221.50. Following the sale, the chief financial officer owned 139,896 shares in the company, valued at $864,557.28. The trade was a 14.21% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 23.70% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a "sell (d-)" rating on shares of 908 Devices in a research report on Wednesday, January 21st. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, 908 Devices has an average rating of "Hold" and a consensus target price of $12.00.

908 Devices Profile

908 Devices Inc NASDAQ: MASS is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company's core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices' portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.

Want to see what other hedge funds are holding MASS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for 908 Devices Inc. (NASDAQ:MASS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.